Kaneka Corporation (JP:4118)
:4118
Want to see JP:4118 full AI Analyst Report?
4118 Stock Chart & Stats
¥4964.00
-¥17.00(-0.46%)
At close: 4:00 PM EST
¥4964.00
-¥17.00(-0.46%)
Day’s Range― - ―
52-Week Range¥3,456.00 - ¥5,286.00
Previous CloseN/A
Volume227.60K
Average Volume (3M)189.42K
Market Cap
¥294.39B
Enterprise Value¥458.96B
Total Cash (Recent Filing)¥44.35B
Total Debt (Recent Filing)¥212.31B
Price to Earnings (P/E)9.1
Beta0.86
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.41%
Share Statistics
EPS (TTM)120.21
Shares Outstanding63,000,000
10 Day Avg. Volume277,740
30 Day Avg. Volume189,416
Financial Highlights & Ratios
PEG Ratio0.79
Price to Book (P/B)0.51
Price to Sales (P/S)0.30
P/FCF Ratio-24.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥5,200.00Price Target Upside4.75% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)442.63
Revenue Forecast (FY)¥849.50B
Bulls Say, Bears Say
Bulls Say
Diversified Business ModelKaneka's operations span performance polymers, electronic/advanced materials, and life-science/nutrition products, providing multiple revenue streams across industrial and consumer end markets. This diversification reduces single-market cyclicality, supports cross-selling, and enhances resilience over months.
Consistent Revenue GrowthThe company shows persistent top-line expansion (recent revenue growth and a roughly 6.4% five-year CAGR), indicating sustained demand and successful market penetration. Durable revenue momentum supports reinvestment, product qualification efforts, and long-term strategic growth in specialty segments.
Solid Operating Cash GenerationRobust operating cash flow demonstrates the core chemicals and specialty materials businesses generate steady cash from operations. This internal cash generation underpins working capital needs, funds strategic investments, and offers a buffer against short-term liquidity stress despite heavy capex cycles.
Bears Say
Negative Free Cash FlowNegative free cash flow driven by elevated capital spending reduces retained liquidity and constrains the company's ability to return capital to shareholders or build cash reserves. If capex remains high, the firm may need external funding or to curb discretionary spending, affecting medium-term financial flexibility.
Compressing Net Profit MarginDespite stable gross margins and improved operating margins, the decline in net profit margin to low single digits signals rising non-operating costs or tax/expense pressures. Sustained margin compression weakens return on sales and limits the company's ability to convert revenue growth into durable shareholder earnings.
Rising LeverageAn increasing debt load and higher debt-to-equity ratio, while moderate, reduce financial flexibility—especially combined with negative FCF and ongoing capex. Elevated leverage raises interest and refinancing risk and could constrain strategic options if macro rates or business shocks worsen over the medium term.
Kaneka News
4118 FAQ
What was Kaneka Corporation’s price range in the past 12 months?
Kaneka Corporation lowest stock price was ¥3456.00 and its highest was ¥5286.00 in the past 12 months.
What is Kaneka Corporation’s market cap?
Kaneka Corporation’s market cap is ¥294.39B.
When is Kaneka Corporation’s upcoming earnings report date?
Kaneka Corporation’s upcoming earnings report date is May 20, 2026 which is in 19 days.
How were Kaneka Corporation’s earnings last quarter?
Kaneka Corporation released its earnings results on Feb 10, 2026. The company reported ¥120.21 earnings per share for the quarter, beating the consensus estimate of N/A by ¥120.21.
Is Kaneka Corporation overvalued?
According to Wall Street analysts Kaneka Corporation’s price is currently Undervalued.
Does Kaneka Corporation pay dividends?
Kaneka Corporation pays a Semiannually dividend of ¥80 which represents an annual dividend yield of 3.41%. See more information on Kaneka Corporation dividends here
What is Kaneka Corporation’s EPS estimate?
Kaneka Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kaneka Corporation have?
Kaneka Corporation has 63,000,000 shares outstanding.
What happened to Kaneka Corporation’s price movement after its last earnings report?
Kaneka Corporation reported an EPS of ¥120.21 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.547%.
Which hedge fund is a major shareholder of Kaneka Corporation?
Currently, no hedge funds are holding shares in JP:4118
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kaneka Corporation
Kaneka Corporation manufactures and sells polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan and internationally. It provides impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, and biodegradable polymer, engineering resin for injection molding, zero birefringence, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; organic EL lighting panels; and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. It also provides dairy products, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, including coenzyme, lactic-acid bacteria, and functional foodstuffs, as well as fertilizers. Kaneka Corporation was incorporated in 1949 and is headquartered in Tokyo, Japan.
4118 Stock 12 Month Forecast
Average Price Target
¥5,200.00
▲(4.75% Upside)
Technical Analysis
Options Prices
Currently, No data available
---